Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Arthritis, Rheumatoid 3Inflammatory Bowel Diseases 2Crohn Disease 2Colitis, Ulcerative 2Lymphoma 1Inflammation 1Hypertension 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Bipolar Disorder 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

Adalimumab 10Etanercept 9Methotrexate 4Infliximab 3tofacitinib 2Rituximab 2Leflunomide 2Abatacept 2tocilizumab 1sarilumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Sulfasalazine 1Prednisone 1Licensure 1Hydroxychloroquine 1Glucocorticoids 1Folic Acid 1Chloroquine 1Certolizumab Pegol 1Azathioprine 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Arthritis, Rheumatoid × Infliximab × Clear all
NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown
290 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT01295151 2016-11-02

SWITCH

University of Leeds

Phase 4 Completed
122 enrolled

Arthritis, Rheumatoid

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡